Mind Medicine (MindMed) Inc.
One World Trade Center
Suite 8500
New York, NY 10007
April 26, 2024
VIA EDGAR
Office of Life Sciences
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Attn: Lauren Hamill
| Re: | Mind Medicine (MindMed) Inc. |
| Registration Statement on Form S-3 | |
| Filed April 2, 2024 | |
| File No. 333-278468 | |
| Request for Acceleration of Effective Date |
To Whom It May Concern:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Mind Medicine (MindMed) Inc. hereby requests that the Securities and Exchange Commission accelerate the effective date of the above-referenced Registration Statement on Form S-3 and declare such Registration Statement effective as of 9:00 a.m., Eastern Time, on April 29, 2024, or as soon thereafter as possible.
Please direct any questions or comments concerning this request to Steve Abrams of Hogan Lovells US LLP at (267) 675-4671. Also, please notify Mr. Abrams when this request for acceleration has been granted.
| Very truly yours, | ||
| Mind Medicine (MindMed) Inc. | ||
| By: | /s/ Mark Sullivan | |
| Name: | Mark Sullivan | |
| Title: | Chief Legal Officer | |